Amplify Seymour Cannabis ETF (CNBS): Price and Financial Metrics ETF
GET POWR RATINGS... FREE!
CNBS Stock Price Chart Interactive Chart >
CNBS Price/Volume Stats - 7 Best ETFs for the NEXT Bull Market
| Current price | $6.62 | 52-week high | $25.92 |
| Prev. close | $6.60 | 52-week low | $6.50 |
| Day low | $6.51 | Volume | 11,400 |
| Day high | $6.71 | Avg. volume | 49,774 |
| 50-day MA | $8.31 | Dividend yield | 0.00001% |
| 200-day MA | $13.10 |
Amplify Seymour Cannabis ETF (CNBS) ETF Bio
The Fund seeks to provide investors capital appreciation. Under normal market conditions, the Fund invests at least 80% of its net assets in the equity securities of global companies engaged in cannabis and hemp-related activities and companies that derive 50% or more of their revenue from the cannabis and hemp ecosystem.
CNBS ETF Info
| Issuer | Amplify ETFs |
| Expense Ratio | 0.75% |
| Asset Class | Equity |
| Sector | Global Equities ETFs |
| Assets Under Management (AUM) | 40.96M |
| Net Asset Value (NAV) | $6.61 |
| Options? | Yes |
| Total Holdings | 35 |
CNBS Top Holdings
| Symbol | Company | % of Total |
| MAPS | WM Technology Inc | 8.04% |
| TLRY | Tilray Inc | 6.21% |
| AFCG | AFC GAMMA INC | 4.35% |
| CARA | Cara Therapeutics Inc | 4.12% |
| JAZZ | Jazz Pharmaceuticals Plc | 4.1% |
CNBS Price Returns
| 1-mo | -20.72% |
| 3-mo | -46.09% |
| 6-mo | -49.77% |
| 1-year | -74.10% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -53.15% |
| 2021 | -19.03% |
| 2020 | 31.94% |
| 2019 | N/A |
| 2018 | N/A |
| 2017 | N/A |
CNBS Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||